ARTICLE | Distillery Therapeutics
Endocrine / Metabolic
December 6, 2016 7:39 PM UTC
Patient sample and mouse studies suggest inhibiting SPT or its components, SPTLC1 or SPTLC2, could help treat diabetes. In samples of subcutaneous adipose tissue from obese Type II diabetes patients, ...